Avivit Neumann

496 total citations
28 papers, 385 citations indexed

About

Avivit Neumann is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Avivit Neumann has authored 28 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Avivit Neumann's work include Renal cell carcinoma treatment (7 papers), Prostate Cancer Treatment and Research (7 papers) and Cancer Genomics and Diagnostics (6 papers). Avivit Neumann is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Prostate Cancer Treatment and Research (7 papers) and Cancer Genomics and Diagnostics (6 papers). Avivit Neumann collaborates with scholars based in Israel, United States and South Korea. Avivit Neumann's co-authors include Avivit Peer, Daniel Keizman, Maya Gottfried, Liat Drucker, Avishay Sella, Svetlana Kovel, Hans J. Hammers, Victoria J. Sinibaldi, Mario A. Eisenberger and Michael A. Carducci and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Avivit Neumann

27 papers receiving 376 citations

Peers

Avivit Neumann
J. Crawford United States
Beth‐Ann Lesnikoski United States
Dianne Lemmon United States
Li Yan Khor Singapore
Young Sun Lee United States
Marta Soares Portugal
J. Crawford United States
Avivit Neumann
Citations per year, relative to Avivit Neumann Avivit Neumann (= 1×) peers J. Crawford

Countries citing papers authored by Avivit Neumann

Since Specialization
Citations

This map shows the geographic impact of Avivit Neumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avivit Neumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avivit Neumann more than expected).

Fields of papers citing papers by Avivit Neumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avivit Neumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avivit Neumann. The network helps show where Avivit Neumann may publish in the future.

Co-authorship network of co-authors of Avivit Neumann

This figure shows the co-authorship network connecting the top 25 collaborators of Avivit Neumann. A scholar is included among the top collaborators of Avivit Neumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avivit Neumann. Avivit Neumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neumann, Avivit, et al.. (2025). Estimation of PHA concentrations from cell density data in Cupriavidus necator. Applied Microbiology and Biotechnology. 109(1). 11–11. 1 indexed citations
2.
Švabík, Kamil, et al.. (2021). Vaginal birth after Cesarean section and levator ani avulsion: a case–control study. Ultrasound in Obstetrics and Gynecology. 58(2). 303–308. 2 indexed citations
3.
Lishner, Michael, Shelly Tartakover‐Matalon, Yaron S. Brin, et al.. (2021). Ribosomal proteins as distinct “passengers” of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication. Translational research. 236. 117–132. 10 indexed citations
4.
Neiman, Victoria, Daniel Keizman, David Sarid, et al.. (2016). Outcome of patients with metastatic chromophobe renal cell carcinoma treated with sunitinib. Annals of Oncology. 27. vi289–vi289.
5.
Keizman, Daniel, Avivit Peer, Avivit Neumann, et al.. (2016). Imaging response during therapy (tx) with radium-223 (Ra-223) for castrate resistant prostate cancer (CRPC) with bone metastases (BM).. Journal of Clinical Oncology. 34(2_suppl). 282–282. 4 indexed citations
6.
Peer, Avivit, Avivit Neumann, Avishay Sella, et al.. (2016). Comparison of abiraterone acetate (Abi) versus ketoconazole (Keto) in chemotherapy-naive patients (CN-pts) with metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 34(2_suppl). 260–260. 1 indexed citations
7.
Gottfried, Maya, Avivit Peer, Avivit Neumann, et al.. (2014). Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factors.. PubMed. 16(6). 347–51. 9 indexed citations
8.
Neiman, Victoria, Maya Gottfried, Hans J. Hammers, et al.. (2014). Clinicopathologic factors associated with the development of sunitinib induced hypertension (HTN) in patients (pts) with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 32(4_suppl). 508–508. 1 indexed citations
9.
Neiman, Victoria, Maya Gottfried, Hans J. Hammers, et al.. (2014). Clinicopathologic factors associated with the development of sunitinib-induced hypertension (HTN) in patients (pts) with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 32(15_suppl). e15551–e15551. 1 indexed citations
10.
Keizman, Daniel, Maya Gottfried, Maya Ish‐Shalom, et al.. (2013). Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib. The Oncologist. 19(1). 51–60. 52 indexed citations
11.
Keizman, Daniel, Maya Gottfried, Maya Ish‐Shalom, et al.. (2012). Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram. The Oncologist. 17(12). 1508–1514. 73 indexed citations
12.
Sella, Avishay, Maya Ish‐Shalom, Maya Gottfried, et al.. (2012). Pretreatment (pre-tx) neutrophil to lymphocyte ratio (NLR) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with ketoconazole (keto): Association with outcome and predictive model.. Journal of Clinical Oncology. 30(15_suppl). 4564–4564. 4 indexed citations
13.
Yossepowitch, Ofer, et al.. (2007). Advanced but Not Localized Prostate Cancer is Associated With Increased Oxidative Stress. The Journal of Urology. 178(4). 1238–1244. 46 indexed citations
14.
Merimsky, Ofer, Rony Weitzen, Tamar Peretz, et al.. (2004). Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2. Annals of Oncology. 15(4). 610–612. 22 indexed citations
15.
Kimhi, Oded, Liat Drucker, Avivit Neumann, et al.. (2004). Fluorouracil induces apoptosis and surface molecule modulation of peripheral blood leukocytes. Clinical & Laboratory Haematology. 26(5). 327–333. 6 indexed citations
16.
Neumann, Avivit, et al.. (2004). Pharmacogenetic correlates of clinical benefit from gemcitabine and platinum in patients with advanced bladder cancer. Journal of Clinical Oncology. 22(14_suppl). 3202–3202. 1 indexed citations
17.
Drucker, Liat, et al.. (2003). The effects of doxorubicin on apoptosis and adhesion molecules of normal peripheral blood leukocytes—an ex vivo study. Anti-Cancer Drugs. 14(5). 383–389. 6 indexed citations
18.
Stemmer, Salomon M., Shulamith Rizel, Izhar Hardan, et al.. (2003). The Role of Irradiation of the Internal Mammary Lymph Nodes in High-Risk Stage II to IIIA Breast Cancer Patients After High-Dose Chemotherapy: A Prospective Sequential Nonrandomized Study. Journal of Clinical Oncology. 21(14). 2713–2718. 50 indexed citations
20.
Drucker, Liat, et al.. (2000). Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity. Cancer. 88(4). 755–760. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026